Drugs / Qishen Granules
Qishen Granules
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT03027375 | Mar 2017 → Dec 2018 | heart failure | Beijing University of Chinese Medicine | Unknown | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT06377761 | May 2023 → Dec 2025 overdue | heart failure | Guangdong Provincial Hospital of Traditional Chinese Medicine | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qishen Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06377761 ↗ |
| Known as | Qishen granule | “Qishen granule (QSG) is a promising traditional Chinese medicine (TCM) treatment” PMID 40770799 ↗ Aug 2025 |
| Known as | QSG | “Qishen granule (QSG) is a promising traditional Chinese medicine (TCM) treatment” PMID 40770799 ↗ Aug 20251“Qishen granules (QSG), a Chinese herbal formula” NCT03027375 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qishen granules (QSG), a Chinese herbal formula” NCT03027375 ↗ |